ARTL News and Press, Artelo Biosciences Inc. From 11/02/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday. Source: f11photo/Shutterstock.com We’ve got earnings reports, analys...

Artelo Biosciences (ARTL +38.3%) has recorded the second biggest intraday gain for the year after H.C. Wainwright initiated its coverage with a Buy recommendation and a 12-month price target of $4 per share to indicate a premium of ~459.0% to the last close. Analyst Vernon Bernardino lists th...

3 Penny Stocks on Reddit to Watch in November 2021 As we inch closer toward the end of the year for penny stocks, many investors are excited about the future. And sticking to the theme of 2021, we continue to see Reddit have a major effect on penny stocks and blue chips . While not ...

Gainers: ABVC BioPharma ABVC +193%. ANI Pharmaceuticals ANIP +49%. Artelo Biosciences (NASDAQ:ARTL) +48%. ION Geophysical (NYSE:IO) +26%. Super League Gaming (NASDAQ:SLGG) +24%. loanDepot LDI +22%. Desktop Metal DM +22%. Evolv (NASDAQ:EVLV) +22%. Comtech Telecommunicatios ...

Gainers: ABVC BioPharma (NASDAQ:ABVC) +250%, ANI Pharmaceuticals (NASDAQ:ANIP) +51%, Artelo Biosciences (NASDAQ:ARTL) +37%, Nutriband (NTRBW) +34%, Regencell Bioscience (NASDAQ:RGC) +15%. Losers: Centessa Pharmaceuticals (NASDAQ:CNTA) -19%, Mi...

SOLANA BEACH, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that Gregory Gorg...

The following slide deck was published by Artelo Biosciences, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Artelo Biosciences, Inc. 2021 Q3 - Results - Earnings Call Presentation

Artelo Biosciences, Inc. (ARTL) Q3 2021 Earnings Conference Call August 18, 2021, 11:45 AM ET Company Participants Andy Yates - Chief Scientific Officer Conference Call Participants Presentation Unidentified Company Representative Thank you so much for everyone who’s joined this mornin...

Solana Beach, California--(Newsfile Corp. - August 11, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL ) , a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced that m...

Study finds no in-vitro pharmacological difference in the antiproliferative, anti-inflammatory, or permeability effects of purified natural versus synthetic CBD Study further validates Artelo’s strategy to develop a synthetic CBD-cocrystal with enhanced pharmaceutical pro...